Postmenopausal osteoporosis is a common disorder accompanied with estrogen deficiency in women. Plants containing phytoestrogens and amino acids have been used in the osteoporosis treatment. The present study aims to evaluate the estrogen-like activity of the Cicer arietinum extract (CAE) and its ability to inhibit osteoclastogenesis process. These achieved by investigating the binding of its active phytoestrogens (genistein, daidzein, formononetin and biochanin A) to the estrogen receptors (ER) α and β of rats and human in silico. In addition, in vivo study on ovariectomized (OVX) rats is performed. For in vivo study, twenty four rats were divided into four groups (n= 6). Group I is the sham control rats which administered distilled water. Groups II, III, and IV are OVX groups which administered distilled water, CAE (500 mg/kg), and alendronate; respectively. The docking study revealed that the phytoestrogens docked into the protein active site with binding energies comparable with that of estrogens (estriol and β-estradiol) which means the similarity between the estrogenic contents of CAE and the ensogenous ones. Additionally, in vivo study revealed that CAE reverse TRAP5b and RANKL levels that drastically increased in the untreated OVX group. But, it trigger upregulation of OPG, enhance the OPG/RANKL ratio and modulate the bone and uterus alterations of OVX group. Phytoestrogens and the bone-protective amino acids contents of CAE could be responsible for their estrogen-like effect and antiosteoporotic activity. These results concluded that CAE is an attractive candidate for developing a potential therapeutic cheap agent used as an alternative to the synthetic estrogen replacement therapy. Further, in vivo validation is required for its clinical application.
Introduction
Postmenopausal osteoporosis is the most common osteoporosis type which become a major problem with significant morbidity and mortality (1) . Where reduction of estrogen increases osteolysis rather than osteogenesis; and consequently induces osteoporosis. Both trabecular and cortical bones are affected by postmenopausal osteoporosis (2) .
Osteoblasts regulate osteoclast activity via cell-cell contact whereby the osteoblast cell-surface receptor activator of nuclear factor κ-B ligand (RANKL) binds to its cognate receptor (RANK). This results in activation of signaling pathways which regulating osteoclast function; as RANKL is a key promoting factor for osteoclast differentiation. Osteoprotegerin (OPG) expressed by osteoblasts and functions as a soluble decoy receptor for RANKL, it competes with RANK to prevent osteoclastogenesis induction (3) . This interaction (OPG with RANK) inhibits osteoclast differentiation consequently prevents bone resorption, thereby is named osteoprotegerin that means "to protect bone" (4) . Hence, the osteoclastogenesis activation mainly depends on the ratio of OPG/RANKL specifically generated in the bone microenvironment. As the serum RANKL concentration does not indicate the bone tissue only due to a variety of cell types express RANKL (5, 6 ). Rogers and Eastell (7) reported that the serological evaluation of OPG is not feasible in all cases because it is possible for the OPG in serum to be linked to another plasma protein and hence become inactive. Thereby, the researchers should be estimate the RANKL and OPG in bone instead of serum. Tanaka et al. (8) considered the RANK/RANKL/OPG axis to be the most relevant therapeutic target for bone destructive diseases. Thus, the search for new regulators for its signaling pathway is considered as a key strategy for bone loss control.
There is an urgent requirement to explore naturally occurring substances especially of plant origin that could prevent bone loss and free from any adverse effects of estrogen replacement therapy and bisphosphonates drugs. Therefore, it would be of great benefit to postmenopausal women to develop plant-derived compounds with estrogenic effects which called phytoestrogens. As the phytoestrogens elicit an estrogenic response by binding with estrogen receptors (ERs). Besides the phytoestrogen importance for the postmenopausal women, proteins represent a key nutrient for bone health and osteoporosis prevention (9) . Previous studies reported that proteins of vegetable source increased the bone mineral density in women, as the amino acids modulate the differentiation of osteoblasts (10, 11) . Thereby, the ongoing study selects chickpea due to its phytoestrogen contents and its higher protein contents in comparison with the other pulses (12) (13) (14) (15) . Chickpea (Cicer arietinum L.) is the third most important pulse crop in production and has a diverse array of potential nutritional and health benefits.
Molecular modeling represents a new area of research that investigate and examine the physical properties and vibrational characteristics of molecules using the great improvements in software and hardware in the last two decades. New drugs are fabricated nowadays using computer-aided drug design as the first step (16) (17) (18) (19) . Also, computer simulation of the reactivity and stability of compounds are used to explore molecules before experimental work. The quantitative structure-activity relationships (QSAR) and molecular docking methods performed in the present investigation to study drug-protein interactions and score the reactivity of compounds docked into the protein active site (16, 17) . The fitting of the drug-like compounds to the protein active/binding site depends on the interaction forces between their atoms. H-bond, Van der Waal's interactions, Columb forces between charges, and ring stacking in aromatic components are the main driving forces that direct the drug-like molecule to the protein's binding site. In addition, water molecules and ions present in the binding site may facilitate ligand binding through H-bond and coordination bonds. Scoring functions test different orientations of the ligand inside the binding cavity and the lowest energy conformation is suggested to be the orientation of choice. The flexibility of side chains and the drug-like molecules represents a favorable choice to mimic the molecular structures at physiological temperature.
Thus, the present study analyze the amino acids of the Cicer aritienum extract (CAE) and investigates the pre-clinical osteoclastogenesis inhibitory effect of CAE against estrogen-deficiency bone loss by examining the structural and biochemical properties of bones. Additionally, the current study give the insight view on the bone OPG/RANKL ratio. Further, the present investigation examine and analyze the histomorphomertry of the uterus to determine if the CAE has an in vivo estrogenic activity or not. Moreover, the reactivity and the binding property of phytoestrogens content (genistein, daidzein, formononetin and biochanin A) of CAE to the rat and human ERα and ERβ was tested in silico using molecular docking simulation study as a trial pilot test for its application on the human beings in the future.
Materials and Methods

Preparation of CAE
Methanolic extract of Cicer arietinum was prepared according to the method adopted by Marzouk et al. (20) . One gram of finely Cicer arietinum seeds powder was mixed with 4 ml of methanol, heated at 60°C for 1 h while being shaken in a water bath. The resulting extract was centrifuged at 10000 rpm, 5 °C for 20 min. The resulting supernatant was filtered through filter paper (Whatman No. 1), concentrated on a rotary evaporator and dried by lyophilizer apparatus.
The percentage yield of the extract was calculated using the following formula: % Yield = Weight of the extract x 100 % Yield = 15.833%
The prepared CAE was stored in a desiccator until use.
Amino acid analysis of CAE
The CAE was analyzed for amino acid content by acid hydrolysis method using the Automatic Amino Acid Analyzer (AAA 400, INGOS Ltd.) according to the method described by Block et al. (21) . The dried ground sample of CAE (100 mg) was hydrolyzed with 6 N HCl (10 ml) in a sealed tube at 110ºC in an oven for 24 h. After hydrolysis, the acid was evaporated to dryness under a vacuum of 80ºC with the occasional addition of distilled water. The HCl free residue was dissolved in 2 ml loading buffer (6.2 M, pH 2.2) using a syringe.
In silico study on human estrogen receptors
Molecular modeling
Molecular modeling software SCIGRESS 3.0 (22) installed on Dell Precision T3500 workstation and HADDOCK (23) web server were used to study the docking of estrogens (estriol and β-estradiol) and phytoestrogens (genistein, daidzein, formononetin and biochanin A) with both of the human ERs α and β.
Geometry optimization
The structures of the estrogens and phytoestrogens were sketched using the medicinal chemistry platform SCIGRESS tools and then geometry optimized using Molecular Mechanics force field (MM3 method). After this, the structures were further optimized using semi-empirical quantum mechanical Parameterization Method 6 (PM6). The optimized structures were then validated by calculating the Infrared vibrational spectra using the same method (PM6) to ensure the reality of the structures. Finally, structures are optimized quantum mechanically by Density Function Theory (DFT) using the B3LYP functional followed by IR calculation using the same basis set. At this point, estrogen and phytoestrogen structures were ready for our study.
Quantitative Structure-Activity Relationships (QSAR) parameters calculation QSAR study was done (using SCIGRESS) to compare the activity and stability of the studied compounds with the standard estrogens. The parameters were calculated for the geometry-optimized structures. The QSAR parameters that used in this study included conformation minimum energy (Kcal/mol), total energy (Kcal/mol), heat of formation (Kcal/mol), dipole moment (Debye), ionization potential (eV), Log P, molar refractivity, polarizability (Ǻ 
Molecular docking
Using experimentally solved structures of both human ER α and β, we made our docking study. The protein data bank files 2Q70, 2QA8, 3Q95 and 3UUD re- 2), and stored at -80 °C for further analysis. The right femur bone was also carefully removed, cleaned and prepared for cortical bone histological examination to investigate microarchitectural changes. The uterus of each rat was also dissected, separated from the surrounding adipose and connective tissues and prepared for histological examination.
Serum estrogen (E2) assay
The serum E2 level was determined by a radioimmunoassay (RIA) kit (DRG Diagnostics, Marburg-Lahn, Germany).
Bone biochemical markers
Bone biochemical markers of OPG, RANKL and TRAP5b were measured in bone homogenate using an ELISA reader. Further, the ratio of OPG/RANKL was calculated to determine the net bone formation. The ratio was calculated after converting the serum RANKL (pmol/g tissue) to ng/ g tissue to unify the unit.
Uterine histological and morphometric examination
Routine histological processes were employed which includes paraffin inclusion, sectioning and hematoxylineosin staining. For morphometric measurements of the uterus, an image analyzer (Leica, QWIN version 3) coupled with a light microscope and the personal computer was used. The uterine morphometrical measurements include; the number of uterine glands, the thickness of the endometrium and myometrium.
Cortical bone histological examination
The right femoral bone was removed and fixed in 10% neutral buffered formalin for 48 h and decalcified in 10% EDTA (pH 7.4) at 4 o C for 4 weeks. After decalcification, each bone sample was embedded in paraffin blocks in a routine manner and cut longitudinally into 5µm sections. Then cortical sections were stained with hematoxylin and eosin.
Statistical analysis
Results of the present study were expressed as presenting human ERα and 1L2J, 1QKM, 1X7J as well as 3OLS representing human ERβ were downloaded from the protein data bank (www.pdb.org) (24) for using in our docking study. We made some modifications to the coordination files as a preparatory step for docking. We get the coordinates of one polypeptide chain from each of the downloaded PDB files (if it has more than one chain) and removed ligands using PyMOL software (25) . In addition, Rattus norvegicus ERβ structure (PDB ID: 1QKN) is downloaded for testing against phytoestrogens. Due to the lack of rat ERα solved structures in the protein data bank, we built 3D structure model from its amino acid sequence using comparative protein modeling (26) . HADDOCK web server was used to perform molecular docking in this study. The easy interface was used in which the required files were the PDB of both protein and ligand and the active amino acids that take part in the interaction. These amino acids are retrieved from solved structures for both human ERα and ER β. Easy mode is used because we only have the amino acids that take part in the interaction with estrogens which we get from the solved structures (previously mentioned PDB files).
At the same time, we do the docking study with different software based on vina scoring function, AutoDock Vina (27) . From HADDOCK and AutoDock Vina; docking scores of estrogens and phytoestrogens were retrieved and the docking poses were taken for comparison using PyMOL software.
Animals
Thirty female 3-4 month-old Wistar albino rats (Rattus norvegicus) were purchased from the animal house of the National Research Center (NRC), Egypt. Rats were housed in polypropylene cages in an air-conditioned room at a temperature of 23 ± 2 °C and under natural day and night cycle. They were fed standard chow pellets and drinking water ad libitum. The rats were acclimated for one week prior the commencement of the experiment.
Ethical considerations
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals, 8th edition. The experimental animal facility and protocol were approved by the Institutional Animal Care and Use Committee (IACUC) (CUFS/F/PHY/03/13) of the Faculty of Science, Cairo University, Egypt. All efforts were made to minimize suffering the surgery.
Osteoporosis induction
Bilateral ovariectomy is a scientifically accepted model of osteoporosis and it was performed as described previously by Sayed et al. (28) . The sham-operated group was handled as the ovariectomized (OVX) group, but the ovaries still intact.
Grouping and treatment
Twenty four rats were randomized into four groups of 6 animals each as shown in figure 1 . Surgery initiated at week 0 and the experiment was terminated at week 10. At the end of treatment period, the rats were eutha- mean+SEM. Data were analyzed by one way ANOVA using the Statistical Package for the Social Sciences (SPSS) program, version 15 (SPSS Institute, Inc., Chicago, IL, USA) followed by Duncan test to compare significance between groups. The difference was considered significant when P value less than 0.05 (P<0.05).
Results
Amino acid content of CAE
The amino acid profile of the present study indicates that the CAE is an excellent source of essential and nonessential amino acids (Table 1) . CAE contains a higher concentration of non-essential amino acids, where the levels of glutamic acid and arginine are remarkably higher than any other amino acid species (Fig. 2) . The present extract (CAE) provides a valuable addition to the nutrient database of amino acid; consequently CAE may be used as amino acid complement without any loss of essential nutrient value.
CAE enhance bone turnover markers and retained the bone structure of OVX rats
The present study revealed that ovariectomy induces E2 deficiency and hence affect some bone remodeling markers. Bone OPG and OPG/RANKL ratio were observed in untreated OVX group relative to sham control group. As shown in table 2, significant elevation of bone RANKL and TRAP5b levels were observed in OVX rats compared to sham. CAE enhance E2, OPG and OPG/RANKL levels as well as suppress RANKL and TRAP5b concentrations. In addition, alendronate improved the bone turnover markers significantly but no change in TRAP5b level was observed.
Histological examination of cortical bone of OVX rats revealed a thinning cortical bone and a dispersion of many resorption pits in the cortex in comparison with sham one (Fig. 3) . OVX rats treated with CAE had thicker cortical bone and no visible resorption pits when compared with untreated OVX rats. Further, the cortical bone of alendronate-treated group was apparently similar to that of the control group.
Morphological analyses of uterus
As shown in figure 4 , ovariectomy resulted in atrophy of the uterus. Since a minimal number of glands in addition to a dramatic decrease in endometrium and myometrium thickness were observed compared with sham control uterus. CAE slightly maintain uterine structure more or less at the level of sham rats, where it can proliferate the uterine endometrium, increased endometrial and myometrial thickness, and endometrial glands numbers. Alendronate treatment to OVX rats increased the abovementioned indices of the uterus. Additionally, the uterine structure becomes hypertrophic and hyperplastic following alendronate.
Quantitative Structure-Activity Relationships (QSAR) Table 3 shows the calculated values of some Quantitative Structure-Activity Relationships (QSAR) parameters. These values are calculated using semi-empirical quantum mechanical parameterization method PM6 for the optimized structures of both estrogens (estriol and β-estradiol) and the phytoestrogens (genistein, daidzein, formononetin and biochanin A). Table  3 shows some parameters that reflect the stability of a structure (conformational minimum energy, dielectric energy, steric energy, total energy and heat of formation) and other parameters that reflect the reactivity of the structure [dipole moment, electron affinity, molar refractivity, the frontier energy gap (LUMO-HOMO), ionization potential, Log P, molecular weight and solvent accessible surface area].
From the first five columns of /mol, respectively) . On the other hand, the dielectric energy of the estrogens is higher than the phytoestrogens. From the remaining columns of table 3 (that reflect structural reactivity), we found that the estrogens have lower dipole moment compared to the phytoestrogens. This implies higher reactivity compared to estrogens. This is supported by the better values of the ionization potentials, Log P values, frontier energy gaps (LUMO-HOMO), molar refractivity values and electron affinities of phytoestrogens compared to estrogens. On the other hand, the estrogens and biochanin A have higher solvent accessible surface areas. This may be in part due to their higher molecular weights compared to the other compounds under our study.
Molecular docking
Rat estrogen rceptors α and β are used to test the binding ability of phytoestrogens and compare it to estrogens. Rat ERβ has solved structure in the protein data bank while rat ERα still not solved experimentally. Phyre2 webserver was used to build a 3D structure for rat ERα from its sequence (GenBank: BAI48013.1) using human estrogen receptor α ligand binding domain (PDB ID: 1XPC) as a homolog (sequence Identity 97%). The model is valid based on Ramachandran plot (29) (94.5% in the most favored region and only 0.8% in the disallowed region), ERRAT (30) (overall quality factor 87.391%) and Verify 3D (31) (83.19% of the residues had an averaged 3D-1D score ≥ 0.2). On the other hand, rat ERβ solved structure (PDB ID: 1QKN) is used in this docking study. AutoDock Vina is used to testing the binding affinity of both estrogens and phytoestrogens to the rat ERα (model) and rat ERβ solved structure. For rat ERα, A41, L82, K92 and G212 are used as flexible during the docking calculations. On the other hand, S252 and E344 were used as flexible during the docking in the case of rat ERβ.
In order to identify the active amino acids of the human ERα and β, this study used the solved structures of human ER with ligands have the same properties of our tested compounds. A collection of ERα structure files (PDB code: 1AS2, 1ERE, 1G50, 1GWR, 1QKU, 1X7R, 2OCF, 2QA8, 3Q95, 3UUD and 4PXM) are studied for their ligand interactions. The ligand in 3Q95 is estraiol and in 1X7R and 2QA8 it is genistein while the rest of structures estradiol is the ligand. For human ERβ, we studied the structures of 3OLL, 3OLS, 1QKM and 1X7J. The amino acids that take part in the interaction with ligands were E353, R394, F404 and H524 for ERα while for ERβ E305, R346, F356 and H475 were the interacting residues. These active amino acids are utilized by HADDOCK web server and AutoDock Vina for the docking study. The present study used these four amino acids for each of the human ERα (PDB codes: 2Q70, 2QA8, 3Q95 and 3UUD) and β (PDB codes: 1L2J, 1QKM, 1X7J and 3OLS) as the active amino acids in HADDOCK easy interface and make our docking without using any restraint files. These amino acids are treated as flexible in AutoDock Vina using AutoDock Tools package (32) . Figures 5 a and 5 b show the docking scores obtained from HADDOCK web server for both estrogens and the phytoestrogens (Figure 5a represent the scores for human ERα complexes while figure 5b represent the scores for human ERβ complexes). The error bars are used because HADDOCK gather the complexes generated which have small Root Mean Square Deviation (RMSD) and represent it by a cluster. Figure 5 
In order to trust our docking study, we compared the solved structures of human ERα (2QA8) and β (1X7J) to the docking complexes we obtained using AutoDock Vina. Figure S1 shows the superposition of the solved (cyan/green for ERα and ERβ, respectively) and the calculated docked (magenta) genistein structures. Hydrogen atoms are missed in the solved structures because X-ray crystallography is the method used to solving the structures. It is obvious the correctness of our docking model since it coincides with the solved structure. Hence we can trust the docking experiment and now we need to know how the phytoestrogens bind to the estrogen receptors.
Some of the docking poses are shown in figure 6 . This figure clarifies the interactions occurred between the ligands (both estrogens and phytoestrogens) and the human ERα (PDB ID 2QA8) and β (PDB ID 1X7J). Amino acids that take part in the interaction with the ligands are represented (lines) and labeled. These are listed in table 4 along with other structures used in this study. The main interaction types that predominate here is the ring stacking (π-stacking) and H-bonding. This is due to the chemistry of the estrogens and the phytoestrogens. Both have aromatic rings and hydroxyl groups that fit inside the aromatic-rich binding sites. The flexibility of four amino acids (based on different structures have different ligands) in each target protein made the Table 4 and figure 6 ).
The main interacting amino acids are mostly the same amino acids recorded from the PDB files which are: E353, R394, F404 and H524 for human ERα and E305, R346, F356 and H475 for human ERβ. Some amino acids also involved in the binding but not recorded in the PDB files (table 4) . This is due to the flexibility in our docking experiment and the water molecules found in some solved structurres of ERβ. Since the chemical structures of the phytoestrogens is similar to that of estrogens (see figure S2) , which consists mainly from aromatic rings and hydroxyl group, the interaction with ER is suggested to be the same with some minimal differences that slightly affect the binding. It is apparent from both figures 5 and 6 that there is no significant difference between the docking scores and poses for both estrogens and phytoestrogens. This implies the ability of phytoestrogens to bind to ER active site similar to normal estrogens. This suggests the possible compensatory effect of phytoestrogen in case of estrogen deficiency.
Discussion
Postmenopausal osteoporosis originated from the cessation of ovarian hormones at menopause which prolongs bone loss. Phytoestrogen and essential amino acids are proven to modulate the growth and the differentiation of osteoblasts and possessing anti-osteoporotic effects (33, 34) . Therefore, the main goal of this study is to find natural treatment gathered these two properties. Cicer arietinum is known for its higher proteinous and phytoestrogen contents (13) (14) (15) . Thus, the present investigation attempt to study the dual action of both phytoestrogen and amino acids contents of Cicer arietinum extract (CAE) and the possible in silico and in vivo mechanisms behind these effects using ovariectomized (OVX) rats as a model of postmenopausal osteoporosis.
The present study revealed that ovariectomy resulted in estrogen depletion which manifested by a significant decrease in the E2 level relative to sham level in addition to the atrophy of the uterus. This is matching with the report of Diel et al. (35) , who disclosed that the uterotrophic assay expresses the estrogenic activity in vivo. The present study evidenced the uterus atrophy histologically, as the uterus of OVX group show marked decrease in the thickness of endometrial and myometrial, a decrease in number of uterine gland. This result is parallel with the result of Koo et al. (36) .
Furthermore, the present work revealed that ovariectomy elevates the bone TRAP5b concentration significantly which reflects the severity of bone resorption in OVX group. Omi and Ezawa (37) mentioned that ovariectomy resulting in an increase in bone resorption. The present study attributes this to the RANK/RANKL/ OPG signaling pathway. Estrogen deficiency up-regulate the production of RANKL; which is one of the responsible cytokines that enhanced osteoclastogenesis and consequently bone loss (38) . Thus, the present study interprets the increased TRAP5b level of OVX rats to estrogen deficiency (manifested in the present study) that in turn stimulate the osteoblast to produce RANKL (which increased in the present study). The latter accelerated osteoclast differentiation and bone loss. This emphasisized the pronounced decreased level of OPG, where estrogen deficiency provokes osteoclastogenesis by down-regulating OPG and consequently suppress the OPG/RANKL ratio. Thus, facilitating the binding of RANKL to RANK receptor and hence activate osteoclast differentiation. The increased bone TRAP5b activity and RANKL simultaneously with the decrease of OPG/RANKL ratio matching with cortical thinning and porosity. This finding is consistent with Fahmy et al. (13) and Sirasanagandla (39) , who found that ovariectomy increased the serum RANKL and TRAP5b and decline the serum OPG levels.
The physiological and morphological alterations induced by ovariectomy were recovered by administration of CAE, as most of the marker levels become almost similar to sham marker levels. CAE resulted in an increase in the E2 level of the OVX group significantly. This shown through restoring the lining of the uterus of the CAE-treated rats to the sham group. This indicates that CAE has a direct estrogenic activity on the uterus. The present study attributes this ability to the phytoestrogen contents of CAE. Where, docking study revealed that genistein, daidzein, formononetin and biochanin A can bind effectively with ERα which is predominantly expressed on the uterus and localized in the nuclei of the uterine glands (40, 41) . This explains that CAE phytoestrogen compounds can act as endogenous estrogen by binding to its receptor binding site. The high docking scores (calculated by HADDOCK and AutoDock Vina) of the CAE phytoestrogen compounds signifies that they can bind to the ERs binding site with a strong binding affinity more or less similar to the standard estriol and β-estradiol. In addition, the interaction pattern of standard estrogens is maintained in phytoestrogens.
Therefore, phytoestrogens can prevent uterus atrophy induced by estrogen deprivation. This explanation is in harmony with Santell et al. (42) , who reported that genistein binds with ERα to improve uterine status.
The increased E2 in the OVX-CAE treated group evoke an increase in the OPG and diminish the RANKL levels. This manifested by the pronounced increase in the OPG/RANKL ratio. Thus, the present study assumed that CAE has the potency to block osteoclastogenesis, since, OPG/RANKL ratio reflect the osteoformation/osteoresorption (43) . CAE may stimulate osteoblastic cells to up-regulate the secretion of OPG which binds with RANKL; consequently reduce the RANK/ RANKL interaction and hence inhibit osteoclastogenesis. The up-regulation of OPG in the CAE group may be due to its phytoestrogen contents which mimic the action of estrogen in up-regulating the OPG normally, and this proved by binding of phytoestrogen contents of CAE with ERs α and β. Albertazzi (44) revealed that genistein binds with ERβ to prevent bone loss. Interestingly, not only the phytoestrogen contents of the CAE participating in the modulation of bone loss; but also its amino acids contents contributing to bone protection and/or bone loss modulation. Recently, it was reported that some of the non-essential amino acids including alanine, arginine, glutamic acid, leucine, lysine and glycine (present in the CAE) play a major role in bone health as they promote osteoblast growth and differentiation (45) . Further, CAE contains a remarkable concentration of arginine which is a key building block to repair the damaged bone and consequently enhance osteoblastogenesis (33, 46) . Goel et al. (47) and Vijayan et al. (48) added that L-arginine and methionine, that existing in the CAE, attenuate bone loss through inhibition of osteoclast. This indicates that CAE may exert positive effects on bone formation which confirmed by increased thickness of the cortical bone, besides its osteoclastogenesis inhibition which affirmed through the decreased level of TRAP5b and lack of porosity in the cortical bone.
In conclusion, CAE has an estrogenic-like activity and is a potent inhibitor of osteoclastogenesis. These effects may be due to its phytoestrogens in combination with its bone-protective amino acids. Thus, CAE confirmed its efficacy in a pre-clinical study but future studies will be needed to evaluate its clinical efficacy for the treatment of osteoporosis in postmenopausal women.
